Autologous Bone-Marrow Mononuclear Cell Transplantation after Acute Myocardial Infarction: Comparison of Two Delivery Techniques
Authors:
- 1 March 2009
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 18 (3) , 343-352
Abstract
The objective of this study was to investigate safety and feasibility of autologous bone marrow mononuclear cells (BMMNC) transplantation in ST elevation myocardial infarction (STEMI), comparing anterograde intracoronary artery (ICA) delivery with retrograde intracoronary vein (ICV) approach. An open labeled, randomized controlled trial of 30 patients admitted with STEMI was used. Patients were enrolled if they 1) were successfully reperfused within 24 h from symptoms onset and 2) had infarct size larger than 10% of the left ventricle (LV). One hundred million BMMNC were injected in the infarct-related artery (intra-arterial group) or vein (intravenous group), 1% of which was labeled with Tc99m-hexamethylpropylenamineoxime. Cell distribution was evaluated 4 and 24 h after injection. Baseline MRI was performed in order to evaluate microbstruction pattern. Baseline radionuclide ventriculography was performed before cell transfer and after 3 and 6 months. All the treated patients were submitted to repeat coronary angiography after 3 months. Thirty patients (57 ± 11 years, 70% males) were randomly assigned to ICA ( n = 14), ICV ( n = 10), or control ( n = 6) groups. No serious adverse events related to the procedure were observed. Early and late retention of radiolabeled cells was higher in the ICA than in the ICV group, independently of microcirculation obstruction. An increase of EF was observed in the ICA group ( p = 0.02) compared to baseline. Injection procedures through anterograde and retrograde approaches seem to be feasible and safe. BMMNC retention by damaged heart tissue was apparently higher when the anterograde approach was used. Further studies are required to confirm these initial data.Keywords
This publication has 16 references indexed in Scilit:
- The REPAIR-AMI and ASTAMI trials: cell isolation proceduresEuropean Heart Journal, 2007
- Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialThe Lancet, 2006
- Autologous bone marrow mononuclear cells labeled with Tc-99m hexamethylpropylene amine oxime scintigraphy after intracoronary stem cell therapy in acute myocardial infarctionJournal of Nuclear Cardiology, 2005
- Monitoring of Bone Marrow Cell Homing Into the Infarcted Human MyocardiumCirculation, 2005
- Plasma Level of B-Type Natriuretic Peptide as a Prognostic Marker After Acute Myocardial InfarctionCirculation, 2004
- Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRIBlood, 2004
- Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 proteinCatheterization and Cardiovascular Interventions, 2004
- Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart FailureCirculation, 2003
- Magnitude and Time Course of Microvascular Obstruction and Tissue Injury After Acute Myocardial InfarctionCirculation, 1998
- The utility of [99mTc]HMPAO-leukocytes for imaging infectionSeminars in Nuclear Medicine, 1994